[Clinical problems in medical mycology: Problem number 51]

Rev Iberoam Micol. 2018 Jan-Mar;35(1):56-58. doi: 10.1016/j.riam.2017.09.001. Epub 2017 Nov 21.
[Article in Spanish]

Abstract

A 48 year-old immunocompetent woman, who had a nodular lesion in the neck and a dense infiltrate at the lower lobe of the left lung, presented at the Mycology Unit of Muñiz Hospital of Buenos Aires City. The pulmonary infiltrate disappeared spontaneously 3 months later. The histopathological study of the nodular lesion showed capsulated yeasts (mucicarmin and alcian blue positive stains) compatible with Cryptococcus. The mycological study of a new sample, obtained by a nodular puncture, allowed the isolation of yeasts, identified as Cryptococcus gattii (VGII). Latex test for Cryptococcus capsular antigen in serum was positive (1/100). CSF cultures rendered negative results. Fluconazole at a daily dose of 800mg was given during 45 days with partial improvement; as cultures from a new clinical sample were positive for Cryptococcus, the antimycotic was changed to itraconazole 400mg/day for 5 months, with an excellent clinical response.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use
  • Antigens, Fungal / blood
  • Cryptococcosis / diagnosis*
  • Cryptococcosis / drug therapy
  • Cryptococcosis / microbiology
  • Cryptococcosis / pathology
  • Cryptococcus gattii / immunology
  • Cryptococcus gattii / isolation & purification*
  • Cysts / microbiology*
  • Female
  • Fluconazole / therapeutic use
  • Fungemia / diagnosis*
  • Fungemia / drug therapy
  • Fungemia / microbiology
  • Fungemia / pathology
  • Humans
  • Lung Diseases, Fungal / diagnosis*
  • Lung Diseases, Fungal / drug therapy
  • Lung Diseases, Fungal / microbiology
  • Lung Diseases, Fungal / pathology
  • Middle Aged
  • Thyroid Diseases / microbiology*

Substances

  • Antifungal Agents
  • Antigens, Fungal
  • Fluconazole